EyeYon Medical

EyeYon Medical

Private
Ness Ziona, Central DistrictHealthcare & Life Scienceshttps://www.eye-yon.com

Last Round

Series C

Mar 15, 2021

Total Funding Raised

$31.5M

Momentum Score

50 /100

Company Overview

EyeYon Medical is a medical device company that develops an ophthalmic contact lens aimed at treating corneal edema by promoting healing and alleviating pain in a non-invasive and user-friendly manner.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

synthetic corneal implantcorneal edema treatmentartificial corneacornea transplant alternativeartificial endothelial layerophthalmic medical deviceMedTechcorneal implantcorneal diseasetherapeutic contact lensFDA Breakthrough Deviceminimally invasive surgeryCE Mark

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EyeYon Medical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

EyeYon Medical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series CMar 15, 2021
Series BMar 21, 2017
VC RoundApr 21, 2015

Key People

Founding team and executive leadership

Nahum Ferera

CEO Co Founder

Founding Team

Dmitry Dubson

Chief Technology Officer

Executive Team

Ethan Nash

Chief Financial Officer

Executive Team

EyeYon Medical Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 15, 2026

    Monthly visitors grew 64% MoM, reaching 1.7K.

  • Oct 8, 2025

    Attended the 43rd ESCRS Congress.

EyeYon Medical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

EyeYon Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about EyeYon Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersNess Ziona, Central District
Employee Range28
Year Founded2011
Last FundingMar 15, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.